John Stubenrauch

John Stubenrauch is a seasoned executive in the biopharmaceutical industry, currently serving as the Chief Technology Officer at Day One Biopharmaceuticals. Previously, John held the position of Chief Operating Officer at Nutcracker Therapeutics and served as Vice President of Commercial Biologics Operations at Gilead Sciences. Additional experience includes roles as Senior Vice President of Product Development and Supply at Immunomedics, and General Manager and Executive Director of Operations at AstraZeneca LP US. John holds a Doctor of Philosophy in Chemical Engineering from the University of Pennsylvania and a Master of Business Administration from The Wharton School, earned between 2004 and 2006.